Delivery Order SPE2DB22D2206-SPE2DB25FJR41
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,133.56 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of 500 tablets of Cetirizine HCL 10 mg. This competitively awarded, firm fixed-price contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical delivery will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $2,119.60 to AmerisourceBergen Drug Corp for Cetirizine HCL 10 mg tablets in unit dose packaging containing 100 tablets. This is a firm fixed price delivery order with no set-aside designation, competitively awarded and due for completion by July 28, 2025. The order will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $5,680.22 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 5 mg tablets (100 count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This delivery order is structured as a firm fixed-price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,528.93 to AmerisourceBergen Drug Corp for 500 tablets of Cetirizine HCL 10 mg, with an ultimate completion date of July 24, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award to supply pharmaceutical products supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,127.36 firm-fixed-price delivery order is for the supply of CETIRIZINE-PSE ER 5-120 MG TAB 12S, a type of pharmaceutical product. The contract has an ultimate completion date of January 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- The Defense Logistics Agency awarded a delivery order valued at $8,787 to AmerisourceBergen Drug Corp for 500 tablets of Cetirizine HCL 10 mg on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award from the agency's Medical Supply Chain operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at...
- The Defense Logistics Agency awarded a $1,491.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Cetirizine HCL 5 mg tablets (100-count packages) on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside contract represents a routine pharmaceutical procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 10 mg tablets in quantities of 100 units under a firm fixed-price contract. The award, valued at $2,591.90, was competitively awarded without set-aside designation and reflects a completion date of August 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order is issued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,202.06 firm fixed-price delivery order is for the supply of CETIRIZINE-PSE ER 5-120 MG TAB 24S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,197.91 firm-fixed-price delivery order is for the supply of 4,562,549,817 units of Cetirizine HCL 5 mg tablets. The contract has an ultimate completion date of October 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJR41Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,979.76 to AmerisourceBergen Drug Corp for the supply of Cetirizine-Pseudoephedrine Extended Release 5-120 mg tablets (24-count packages). This non-set-aside, firm fixed price delivery order was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction typical of the company's extensive federal medical procurement portfolio. This award is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. As the prime contractor on this comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems and other federal medical programs worldwide. The company's status as a major pharmaceutical distributor and its demonstrated capability to compete successfully for federal medical procurement requirements position it as a critical vendor for the Defense Logistics Agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 8/27/25 |